Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 640-645

  Kerbaul, François ^a   Collart, Frédéric ^b   Giorgi, Roch ^c,d,e   Ibrahim, Zouher ^b   Guillen, Jean Claude ^a   Gil, Jean Marie ^b   Saadjian, Alain ^c,d,e   Mouly Bandini, Annick ^b   Habib, Gilbert ^b   Gouin, François ^a   Guieu, Régis ^c,d,e  

^a Service d anesthésie et de réanimation   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d HÔPITAL NORD   (France)

^e INSERM   (France)

Author keywords

Adenosine; Cardiopulmonary bypass; Hemodynamics

Indexed keywords

ADENOSINE;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MEAN ARTERIAL PRESSURE; OPERATING ROOM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

ADENOSINE; AGED; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR DISEASES; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 33644595055     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000201005.34203.50     Document Type: Article

References (40)

1. Laffey JG, Boylan JF, Cheng DCH: The systemic inflammatory response to cardiac surgery. Anesthesiology 2002; 97:215-252
2. Kerbaul F, Guidon C, Lejeune PJ, et al: Hyperprocalcitonemia is related to postoperative severe SIRS associated with coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2002; 16:47-53
3. Wan S, Leclerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997; 112(3):676-692
4. Menasché P: The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 1995; 10:597-604
5. Carrel T, Englberger L, Mohacsi P, et al: Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance. J Card Surg 2000; 15:347-353
6. Newholmes EA, Leech AR: Pathways for the degradation of purines and pyrimidine nucleotides. In: Biochemistry for the Medical Sciences. 5th Edition. Chichester (Ed). John Wiley & Sons, New York, 1992, pp 507-508
7. Sollevi A: Cardiovascular effects of adenosine in man: Possible clinical implications. Prog Neurobiol 1986; 27:319-349
8. Plagemann PG: Transport and metabolism of adenosine in human erythrocytes: Effects of transport inhibitors and regulation by phosphate. J Cell Physiol 1986; 128:491-500
9. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50:413-492
10. Fredholm BB, Arslan G, Halldner L, et al: Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:364-374
11. Saadjian AY, Paganelli F, Juin MA, et al: Plasma beta-endorphin and adenosine concentration in pulmonary hypertension. Am J Cardiol 2000; 85:858-863
12. Martin C, Leone M, Viviand X, et al: High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 2000; 28:3198-3202
13. Rosenhek R, Binder T, Porenta G, et al: Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343:611-617
14. The Joint European Society of Cardiology/ American College of Cardiology Committee. Myocardial infarction redefined: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000; 21:1502-1513
15. Provenchère S, Plantefève G, Hufnagel G, et al: Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factors, and effect on clinical outcome. Anesth Analg 2003; 96:1258-1264
16. Feindt P, Volkmer I, Seyfert U, et al: Activated clotting time, anticoagulation, use of heparin, and thrombin activation during extracorporeal circulation: Changes under aprotinin therapy. Thorac Cardiovasc Surg 1993; 41:9-15
17. Muckart DJJ, Bhagwanjee S: American college of chest physicians/society of critical care medicine consensus conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25:1789-1795
18. Fagon JY, Chastre A, Novara P, et al: Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993; 19:137-144
19. Nashef SAM, Roques F, Michel P, et al., and the EuroSCORE Study Group. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13
20. Parsonnet V, Dean D, Bernstein AD: A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989; 79 (suppl I):I-3-I-12
21. Guieu R, Paganelli F, Sampieri F, et al: The use of HPLC to evaluate the variations of blood coronary adenosine levels during percutaneous transluminal angioplasty. Clin Chim Acta 1994; 230:404-409
22. Guieu R, Peragut JC, Roussel P, et al: Adenosine and neuropathic pain. Pain 1996; 68:1-5
23. Saadjian AY, Paganelli F, Gaubert ML, et al: Adenosine plasma concentration in pulmonary hypertension. Cardiovasc Res 1999; 43:228-236
24. Seghaye MC, Duchateau J, Grabitz RG, et al: Complement activation during cardiopulmonary bypass in infants and children: Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106:978-987
25. Partrick DA, Moore EE, Fullerton DA, et al: Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 1999; 86:42-49
26. Wu SN, Linden J, Visentin S, et al: Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline. Circ Res 1989; 65:1066-1077
27. Conlay LA, Conant JA, de Bros F, et al: Caffeine alters adenosine plasma levels. Nature 1997; 389:136
28. Maire JC, Medilanski J, Straub RW: Release of adenosine, inosine and hypoxanthine from rabbit non-myelinated fibres at rest and during activity. J Physiol 1984; 357:67-77
29. Saadjan AY, Lévy S, Francheschi F, et al: Role of endogenous adenosine as modulator of syncope induced during tilt test. Circulation 2002; 106:569-574
30. Mosqueda-Garcia R, Tseng CJ, Appalsamy M, et al: Modulatory effects of adenosine on baroreflex activation in the brainstem of normotensive rats. Eur J Pharmacol 1989; 174:119-122
31. Colson P, Ryckwaert P, Coriat P: Renin angiotensin system and anesthesia. Anesth Analg 1999; 89:1143-1155
32. Law WR, Valli VE, Conlon BA: Therapeutic potential for transient inhibition of adenosine deaminase in systemic inflammatory response syndrome. Crit Care Med 2003; 31:1475-1481
33. Cronstein BN: A novel approach to the development of anti-inflammatory agents: Adenosine release at inflamed sites. J Invest Med 1995; 43:50-57
34. Sullivan GW: Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Invest Drugs 2003; 4:1313-1319
35. Mentzer RML, Rahko PS, Molina-Viamonte V, et al: Safety, tolerance, and efficacy of adenosine as an additive in blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 1997; 79:38-43
36. Dobson GP, Jones MW: Adenosine and lidocaine: A new concept in nondepolarising surgical myocardial arrest, protection and prevention. J Thorac Cardiovasc Surg 2004; 127:794-805
37. Mentzer BM, Rahko PS, Canver CC, et al: Adenosine reduces postbypass transfusion requirements in humans after heart surgery. Ann Surg 1996; 224:523-530
38. Ledent C, Vaugeois JM, Schiffmann SN, et al: Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997; 388:674-678
39. Bohm M, Schmitz W, Scholz H: Adrenaline, adenosine, and feedback. Lancet 1985; 1:1157
40. Dobson JG Jr, Fenton RA: Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res 1997; 34:337-347